|Tested species reactivity||Non-human primate, Rat|
|Published species reactivity||Rat|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Activated, Lewis rat derived microglial cells.|
|Contains||0.09% sodium azide|
|Storage Conditions||4°C or -20°C if preferred|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Flow Cytometry (Flow)||1/10 -1/100|
|Immunofluorescence (IF)||Assay Dependent|
|Immunohistochemistry (Frozen) (IHC (F))||1/10-1/100|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 2 publications below|
Clone TLD-3A12 has been shown to partially block the proliferative response of antigen-specific CD4+ T cells to antigen-presenting cells and relevant antigen.
For FACS analysis, use 10ul of the suggested working dilution to label 1x10^6 cells in 100ul.
PECAM-1 (CD31), is a type 1 transmembrane protein expressed primarily on endothelial cells, platelets and leucocytes.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Identifying blood-brain-barrier selective single-chain antibody fragments.
MA1-81051 was used in immunohistochemistry to identify antibodies that bind antigens present at the blood brain barrier
|Jones AR,Stutz CC,Zhou Y,Marks JD,Shusta EV||Biotechnology journal (9:664)||2014|
Erythropoietin protects against doxorubicin-induced heart failure.
MA1-81051 was used in immunohistochemistry to study the ability of erythropoeitin to protect against heart failure induced by treatment with the cancer drug doxorubicin
|Ammar HI,Saba S,Ammar RI,Elsayed LA,Ghaly WB,Dhingra S||American journal of physiology. Heart and circulatory physiology (301:H2413)||2011|